Order results by:
| Issue | Title | |
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... of the influence of various representatives of the anticoagulants group on bone tissue. The article analyzes ..." | ||
| Vol 11, No 3 (2015) | THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION | Abstract similar documents |
| I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko | ||
| "... Aim. To study the effects of nebivolol on bone mineral density (BMD) in postmenopausal women ..." | ||
| Vol 4, No 2 (2008) | ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? | Abstract similar documents |
| A. L. Komarov, E. P. Panchenko | ||
| "... Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed ..." | ||
| Vol 5, No 3 (2009) | ANTICOAGULANTS IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 14, No 1 (2018) | UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME | Abstract similar documents |
| O. V. Krikunova, R. I. Stryuk | ||
| "... Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... on bone mineral density and fractures associated with osteoporosis. The mechanisms of action of drugs ..." | ||
| Vol 17, No 6 (2021) | Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 | Abstract similar documents |
| I. S. Yavelov | ||
| "... This review discusses reasons for prolonged use of anticoagulants after discharge of patients ..." | ||
| Vol 12, No 6 (2016) | THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| E. A. Smirnova, S. S. Yakushin | ||
| "... The article discusses the choice of anticoagulant in different patterns of acute coronary syndrome ..." | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... of venous thromboembolism (VTE) compared with low molecular weight heparin (LMWH)/warfarin and other new ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... Aim. To study the structure of anticoagulant prescription in a general hospital to identify trends ..." | ||
| Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
| A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
| "... for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accompanied by some ..." | ||
| Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
| S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
| "... to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which ..." | ||
| Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
| К. V. Lobastov, I. V. Schastlivtsev | ||
| "... (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... Background. Anticoagulants (AC) are the high-risk drugs. Their safety closely depends on physician ..." | ||
| Vol 5, No 2 (2009) | POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION | Abstract similar documents |
| N. J. Hozjainova, V. M. Tsareva, T. V. Brook, M. S. Bezaltynnyh | ||
| "... Aim. To study effect of the bone metabolism modulator strontium ranelate on bone mineral density ..." | ||
| Vol 16, No 6 (2020) | Assessment of Subclinical Manifestations of Atherosclerosis of Coronary and Peripheral Arteries and Bone Strength Parameters in Women | Abstract PDF (Eng) similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, M. A. Myagkova, V. E. Novikov, O. Yu. Isaykina, O. M. Drapkina | ||
| "... of the peripheral vascular wall and bone strength indices. Material and methods. In a cross-sectional study were ..." | ||
| Vol 19, No 6 (2023) | Body composition and functional activity in men with heart failure | Abstract similar documents |
| I. A. Skripnikova, E. K. Yaralieva, R. P. Myasnikov, O. V. Kulikova, V. E. Novikov, O. V. Kosmatova, V. A. Vygodin, O. M. Drapkina | ||
| "... , lean and bone body mass) was carried out using dual-energy X-ray absorptiometry (DXA). Physical ..." | ||
| Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
| A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
| "... The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy ..." | ||
| Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
| A. V. Rudakova | ||
| "... to patients’ death. The prevention of VTE events suggests the prescription of low molecular weight heparin ..." | ||
| Vol 19, No 5 (2023) | Relationship between parameters of subclinical atherosclerosis and osteoporosis and their prognostic significance: data from the prospective studies | Abstract similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, T. T. Tsoriev, O. Yu. Isaykina, O. M. Drapkina | ||
| "... , it is not possible to define cause-effect relationship between vascular changes and decreased bone mass, as well ..." | ||
| Vol 19, No 1 (2023) | Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women | Abstract similar documents |
| O. Yu. Isaykina, I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, V. E. Novikov, T. T. Tsoriev | ||
| "... Aim. To study associations between arterial stiffness and bone mineral density in postmenopausal ..." | ||
| Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
| A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
| "... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
| Vol 17, No 3 (2021) | Prevalence of Musculoskeletal Disorders in Patients with Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, K. E. Krivoshapova, V. L. Masenko, E. A. Wegner, А. N. Kokov, S. A. Pomeshkina, O. L. Barbarash | ||
| "... osteoporosis (90.6% vs. 9.4%). Furthermore, due to combination of low bone density (osteopenia/osteoporosis ..." | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 15, No 3 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State | Abstract similar documents |
| I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova | ||
| "... ), and bone-anabolic therapy, which includes teriparatide, were studied. However, there are a few such studies ..." | ||
| Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev | ||
| "... Aim. To evaluate the effectiveness of the anticoagulant choice algorithm in the prevention ..." | ||
| Vol 17, No 2 (2021) | Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic | Abstract similar documents |
| S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev | ||
| "... Aim. To study the current state of the anticoagulant's prescription in elderly and senile patients ..." | ||
| Vol 18, No 1 (2022) | Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev, K. G. Pereverzeva, A. Yu. Timakova, A. S. Galus, S. S. Yakushin | ||
| "... Aim. To assess the adherence of doctors and patients to anticoagulant therapy for atrial ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... Oral anticoagulant therapy is widely used in different patients for the prevention and treatment ..." | ||
| Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
| M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... ) in patients receiving continuous direct oral anticoagulant (DOAC) therapy. Material and methods. Data from ..." | ||
| Vol 10, No 4 (2014) | MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| E. A. Belikov, K. V. Davtyan, O. N. Tkacheva | ||
| "... anticoagulants. ..." | ||
| Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
| "... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... Aim. To assess the compliance of nephroprotective and anticoagulant therapy in patients ..." | ||
| Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
| A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
| "... parameters of new oral anticoagulants. The review presents data from studies investigating the effect of gene ..." | ||
| Vol 9, No 4 (2013) | COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS | Abstract similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova | ||
| "... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..." | ||
| Vol 16, No 5 (2020) | Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage | Abstract similar documents |
| N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
| "... Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants ..." | ||
| Vol 17, No 3 (2021) | Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey | Abstract similar documents |
| K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev | ||
| "... Aim. To assess the duration of the anticoagulant treatment of venous thromboembolism (VTE ..." | ||
| Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract similar documents |
| S. G. Kanorskii | ||
| Vol 5, No 3 (2009) | SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS | Abstract similar documents |
| E. S. Kropacheva | ||
| "... The safety of anticoagulant therapy is discussed. Warfarin position in prevention of thrombotic ..." | ||
| Vol 11, No 1 (2015) | ON THE SELECTION OF DRUGS DOSAGE REGIMEN | Abstract similar documents |
| E. N. Bochanova | ||
| Vol 11, No 2 (2015) | CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION | Abstract similar documents |
| V. N. Shishkova | ||
| Vol 9, No 2 (2013) | ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS | Abstract similar documents |
| O. V. Shatalova, O. N. Smuseva, A. S. Maslakov | ||
| "... accounted for by indirect- acting anticoagulating agents — 66.7% (12/18), direct-acting anticoagulants — 22 ..." | ||
| Vol 11, No 6 (2015) | Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events | Abstract similar documents |
| O. V. Shatalova | ||
| Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
| "... ) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke ..." | ||
| Vol 14, No 4 (2018) | Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice | Abstract similar documents |
| N. M. Vorobyeva, O. N. kacheva | ||
| "... of anticoagulants in real clinical practice and questions of adherence of patients to anticoagulant therapy ..." | ||
| Vol 12, No 4 (2016) | The use of oral anticoagulants in patients with atrial fibrillation: cohort study data | Abstract similar documents |
| O. V. Gaisenok, A. S. Leonov | ||
| "... Aim. To study the rate of prescription of oral anticoagulants (OAC) in patients with atrial ..." | ||
| Vol 9, No 5 (2013) | APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA | Abstract similar documents |
| D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev | ||
| "... response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral ..." | ||
| Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
| A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
| "... of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017. Material and methods ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... in direct oral anticoagulants (DOACs), the possibility of using which in LVT is being actively studied ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... The last decade has dramatically changed the strategy of anticoagulant therapy in patients ..." | ||
| Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... the efficacy and safety of the use of direct oral anticoagulants (DOACs) in clinical practice. Data on drug ..." | ||
| Vol 12, No 2 (2016) | THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE | Abstract similar documents |
| S. V. Moiseev | ||
| "... New oral anticoagulants that inhibit factor Xa (rivaroxaban, apixaban, edoksaban) or thrombin ..." | ||
| Vol 13, No 1 (2017) | DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT | Abstract similar documents |
| D. А. Napalkov, A. A. Sokolova, V. V. Fomin | ||
| "... anticoagulants, apixaban is associated with the best adherence to treatment and lowest bleeding incidence ..." | ||
| Vol 13, No 5 (2017) | DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov | ||
| "... favorable profile of drug interaction in comparison with other new oral anticoagulants (NOAC). The basis ..." | ||
| Vol 14, No 1 (2018) | NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| Ju. P. Skirdenko, N. A. Nikolayev | ||
| "... as predictors of choice of optimal anticoagulant therapy in patients with atrial fibrillation (AF). Material ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... Aim. To study the structure and incidence of the in-hospital anticoagulants prescription ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 9, No 2 (2013) | ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES | Abstract similar documents |
| Z. M. Safiullina, S. V. Shalaev | ||
| "... Studies data on new anticoagulants, direct oral thrombin inhibitor (dabigatran) and direct ..." | ||
| Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
| M. Yu. Gilyarov | ||
| Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues ..." | ||
| Vol 16, No 6 (2020) | The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... The administration of oral anticoagulants in elderly patients with geriatric syndromes ..." | ||
| Vol 17, No 1 (2021) | Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction | Abstract similar documents |
| Z. D. Kobalava, A. A. Shavarov, M. V. Vatsik-Gorodetskaya | ||
| "... anticoagulant has unique pharmacologic properties of which clinician should be aware to optimally manage ..." | ||
| Vol 2, No 3 (2006) | EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS | Abstract similar documents |
| A. P. Momot, O. V. Bespalova, E. N. Vorobyova | ||
| "... The anticoagulants of indirect action during many years serve drugs of basic prophylaxis ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova | ||
| "... A recently published article [1 ] on the problems of anticoagulant therapy in patients ..." | ||
| Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... The article discusses issues related to the prescription of anticoagulant therapy to elderly ..." | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... . In addition, they emphasize the role of anticoagulant therapy as a preventing tool for the development ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova | ||
| "... ) on the problems of anticoagulant therapy in patients with frailty syndrome contains two statements which highlight ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... микроальбуминурии и β2-микроглобулинурии, изучались показатели метаболизма липидов и глюкозы, заполнялись опросники ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... Цель. Изучить влияние терапии корректором метаболизма милдронатом на липидный спектр, факторы ..." | ||
| Vol 3, No 4 (2007) | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE | Abstract similar documents |
| I. V. Sergienko, M. E. Bugriy, T. V. Balahonova, G. A. Tkachev, V. B. Sergienko | ||
| Vol 12, No 1 (2016) | Gut microbiota – a new companion on the path of cardiovascular diseases progression: surprising roles of long-time neighbors | Abstract similar documents |
| O. M. Drapkina, A. N. Kaburova | ||
| Vol 17, No 4 (2021) | Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... of real-life clinical trials to assess the effects of direct oral anticoagulants are discussed. ..." | ||
| Vol 12, No 3 (2016) | THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE | Abstract PDF (Eng) similar documents |
| A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko | ||
| "... to anticoagulation therapy in these patients. Keywords: new oral anticoagulants, apixaban, pharmacokinetics, atrial ..." | ||
| Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
| S. R. Gilyarevskiy | ||
| "... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..." | ||
| Vol 5, No 1 (2009) | CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY | Abstract similar documents |
| Yu. A. Bunin | ||
| "... stratification) of different antiarrhythmic drugs and anticoagulants are described. Perspectives in improvement ..." | ||
| Vol 13, No 5 (2017) | WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT | Abstract similar documents |
| S. Yu. Martsevich, Y. V. Lukina | ||
| "... Oral anticoagulant (OAC) therapy is currently gaining special importance due to the significant ..." | ||
| Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
| D. A. Napalkov, A. V. Zhilenko | ||
| "... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..." | ||
| Vol 7, No 5 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES | Abstract similar documents |
| Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy | ||
| Vol 9, No 3 (2013) | ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT | Abstract similar documents |
| E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts | ||
| "... are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties ..." | ||
| Vol 15, No 6 (2019) | Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova | ||
| "... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..." | ||
| Vol 16, No 1 (2020) | Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) | Abstract similar documents |
| N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva | ||
| "... belongs to the number of popular anticoagulants which along with its efficiency not infrequently alters ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... Aim. To study the frequency of prescribing anticoagulant therapy in outpatients with AF ..." | ||
| Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
| N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
| "... are at high risk of stroke. The direct oral anticoagulants are indicated for them. The choice of a drug should ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
| Vol 16, No 4 (2020) | The Controversy Continues Again: which Direct Anticoagulant is More Effective and Safe when Administered to Patients with Atrial Fibrillation? | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 16, No 5 (2020) | New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
| K. B. Mirzaev, D. V. Ivashchenko, I. V. Volodin, E. A. Grishina, K. A. Akmalova, A. A. Kachanova, A. I. Skripka, R. M. Minnigulov, T. E. Morozova, O. A. Baturina, A. N. Levanov, T. V. Shelekhova, A. I. Kalinkin, D. A. Napalkov, A. A. Sokolova, D. A. Andreev, I. N. Sychev, P. O. Bochkov, D. A. Sychev | ||
| "... ), who had hemorrhagic complications during taking direct oral anticoagulants. To find new ..." | ||
| Vol 16, No 5 (2020) | Clinical Case of Complicated Thrombophilia in a Patient with Ulcerative Colitis | Abstract similar documents |
| S. A. Boldueva, I. V. Yarmosh, A. N. Dolinova, Z. G. Kaloeva, M. Yu. Serkova, V. M. Avramova | ||
| "... was continued. At the same time, anticoagulant therapy was started, and antibiotics were canceled. As a result ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... in patients with acute coronary syndrome (ACS) undergoing anticoagulants for atrial fibrillation using ..." | ||
| Vol 17, No 2 (2021) | Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran | Abstract PDF (Eng) similar documents |
| N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev | ||
| "... . The anticoagulant therapy should be prescribed to prevent thromboembolic events. According to randomized clinical ..." | ||
| Vol 17, No 2 (2021) | Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage | Abstract similar documents |
| A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov | ||
| "... Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy ..." | ||
| Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
| Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
| Vol 15, No 3 (2019) | Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation | Abstract similar documents |
| L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin | ||
| "... men and 75 women) who received anticoagulant therapy (ACT) and underwent planned surgery was carried ..." | ||
| Vol 15, No 4 (2019) | Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..." | ||
| Vol 17, No 6 (2021) | Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 | Abstract similar documents |
| A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov | ||
| "... of direct oral anticoagulants increased in 2020 compared to 2016 (р<0.001). For patients with a high risk ..." | ||
| Vol 17, No 6 (2021) | Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation | Abstract similar documents |
| T. V. Pavlova | ||
| "... approach to treatment, and their management is a complex clinical task. The direct oral anticoagulant ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow ..." | ||
| 1 - 100 of 241 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
